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 Lidocaine prevents spinal cord neuronal damage of Kainic acid injected rats  
 Lidocaine improves motor and sensitive performance of Kainic acid injected rats 




Motor Neuron Disease disorders, described in domestic animals, are characterized by 
neuronal degeneration at the spinal cord. Excitotoxicity is a crucial factor for the 
selective loss of these neurons, being the fundamental processes involved in lesion 
progression after spinal cord injury, where glutamate is one of the main 
neurotransmitters involved. Kainic acid (KA) resembles the effects induced by the 
pathological release of glutamate. Lidocaine administered by different routes exerts 
some neuroprotective effects in the CNS. The aim of the present work was to determine 
whether lidocaine simultaneously injected with KA into the spinal cord could prevent 
the excitotoxic effects of the latter. Sprague-Dawley rats were injected by 
intraparenchymal route with KA or with KA plus 0.5% lidocaine into the C5 segment. 
Sham rats were injected with saline. Animals were motor and sensory tested at 0, 1, 2, 3, 
7 and 14 post-injection days and then euthanized. Sections of the C5 segment were used 
for histological and immunohistochemical analysis. No KA-induced motor and sensitive 
impairments were observed when lidocaine was simultaneously injected with KA. 
Moreover, neuronal counting was statistically higher when compared with KA-injected 
animals. Thus, lidocaine could be considered as a neuroprotective drug in diseases and 
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1. Introduction 
Motor neuron disease (MND) is an entity that encompasses neurodegenerative disorders 
of α or lower motor neurons in the spinal cord of domestic animals, being excitotoxicity 
a crucial factor for the selective loss of these neurons [1]. Furthermore, excitotoxicity is 
one of the fundamental processes involved in lesion progression after spinal cord injury 
(SCI) being glutamate one of the main neurotransmitters involved [2; 3].  
Neurons are more vulnerable to excitotoxicity than glial cells [4]. Within neuronal 
population dorsal and ventral horn neurons show kainate receptors [5] and can react to 
KA action with different susceptibility, which may depend on the differential 
expression of calcium binding proteins and enzymatic system to counteract the 
deleterious effect of KA or glutamate [6]. 
Several neurodegenerative disorders were predominantly described in dogs, cats, cows, 
horses and pigs [7]. They were characterized by neuronal body and axonal degeneration 
at the spinal cord [1;7]. Pathogenesis of MND might be explained by the great amount 
of calcium permeable AMPA/kainate receptors in these neurons, which would lead to 
mitochondrial damage and free radical production. Accumulation of these reactive 
oxygen species would damage the surrounding astrocytes and reduce the uptake of 
glutamate by these cells [2;3]. As a result, the extracellular concentration of glutamate 
would markedly increase and exacerbate the process [1]. 
Kainic acid (KA), a cyclic analogue of glutamate, induces damage that resembles the 
effects induced by the pathological release of glutamate. An excitotoxic SCI model that 













a transient excitotoxic stress as the trigger mechanism, followed by secondary phase of 
damage, mainly induced by the release of glutamate from the affected cells [9].  
Local anesthetics are used for spinal, epidural and local anesthesia as well as peripheral 
nerve block [10]. Also, in vitro and in vivo studies have shown that lidocaine is 
protective against hypoxia and neuronal injury induced by ischemia [11;12].  
Although the intrathecal route is usually used to treat insults occurring at the spinal 
cord, the local drug delivery via intraparenchymal infusions has gained increased 
consideration for the treatment of some neurodegenerative disorders [13] since it will 
more precisely determine the effect of the drugs in direct contact with the structures in 
which their activities are to be determined [14].  
The aim of the present work was to determine the effects of a simultaneous injection of 
lidocaine and KA to analyze whether lidocaine can block the KA induced harmful 
effects. Here, our hypothesis states that co-administration of lidocaine with KA would 
block or at least restrict the damage produced by the excitotoxic drug.  
All data collected using this approach could serve as a starting point for supporting 
subsequent therapeutic protocols for the treatment of MND. 
 
2. Materials and methods 
2.1. Animals 
Young (3-5-month-old, 250-450 g) male Sprague-Dawley rats (n = 90) (Table 1), raised 
in our rat colony, were used. Animals were housed in a temperature-controlled room (22 
± 2°C) on a 12:12 h light/dark cycle. Food and water were available ad libitum. All 
experiments with animals were performed according to the recommendations of the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health 













School of Veterinary Sciences, National University of La Plata Institutional Committee 
for Care and Use of Laboratory Animals (CICUAL), Code 45-1-14 T. All efforts were 
made to minimize the number of animals used and their suffering.  
 
2.2. Handling of animals and drugs injection 
On experimental day 0, rats (Table 1) were anesthetized with ketamine hydrochloride 
(40 mg/kg; i.p.) plus xylazine (8 mg/kg; i.m.) and placed in prone position. Then 
intraparenchymal injections were performed [15]. Thus, 5 microliters either of the 
1 mM KA (KA1 group) [8], 0.5% lidocaine (L05 group) [16], lidocaine + KA 
(KA1L05) or 0.9% saline (sham) were discharged at a rate of 1 µl/min, at the C5 spinal 
cord segment right side (ipsilateral). Animals were checked periodically until they woke 
up. No abnormal respiratory frequency nor respiratory noises were detected. In no case, 
animals required manual emptying of the bladder.   
Immediately before surgery both lidocaine (Xylocaine® 2%, AstraZeneca, Haedo, 
Buenos Aires, Argentina) and KA (Sigma-Aldrich, Inc., St. Louis, MO, USA) were 
diluted in 0.9% saline solution and kept at 4°C until use.  
2.3. High-performance liquid chromatography (HPLC) study 
To determine whether there exists chemical interaction between lidocaine and KA that 
might interfere with the effects of each drug, a HPLC analysis was performed at the 
established concentrations. The mix solution of KA1 and L05 was compared with 0.5% 
lidocaine and 1 mM KA. All of them were diluted in saline solution (0.9%), used as 
vehicle.  
Each sample was analyzed using a HPLC device (HPLC-MS Agilent 1100 LC-MSD) 
with a C-18 column (5 µm particle size, 4.6 x 150 mm), equipped with a mass 













positive and negative mode. An isocratic mobile phase mixture of acetonitrile and 0.5% 
aqueous formic acid, 70:30 were used. 
Each analyte was eluted individually and unaltered, which confirm that lidocaine and 
KA do not interact at the selected concentrations (data no shown). 
 
2.4. Behavioral tests  
Behavioral tests were performed the same day, with an interval of 20 minutes between 
them. All rats were submitted to a set of motor and sensitive tests at the beginning of the 
experiment (day 0), and at each analyzed time point (days 1, 2, 3, 7, and 14 post-
injection - pi) until euthanasia (Table 1).  
 
2.4.1. Heat sensitivity test 
The hot-plate test [17-19] was carried out using a 15 cm diameter hot-plate, set at 55 ± 
1°C. The time (measured in sec) between placement (time zero) and licking of their 
forepaws or jumping (whichever occurred first) was considered as the response latency. 
A 20 sec cut-off was used to prevent tissue damage of non-sensitive animals. Three 
measures at 2-min-intervals were taken per session. 
 
2.4.2. Suspension from a horizontal wire mesh pole 
The time during which rats could sustain their own weight was determined by placing 
the animals on a horizontal wire mesh pole [20]. The latency taken by the animals to fall 
was recorded as the average of three consecutive attempts per sessions. 













This test was used to examine forelimb coordination during skilled walking [8, 21]. 
Scoring system ranging from 0 (abnormal) to 6 (perfect) was used [21]. Only scores 
between 0 and 2 were considered as error [22]. Ipsilateral and contralateral limbs were 
evaluated separately. Errors/no-errors percent of the total number of steps in each trial 
was calculated. Trials were recorded, and videos analyzed frame-by-frame to classify all 
the steps per group. 
 
2.5. Euthanasia, specimen collection and processing  
Animals of all groups were euthanized either at 1, 2, 3, 7 or 14 pi days (Table 1). 
Immediately before euthanasia rats were anesthesized with ketamine hydrochloride (40 
mg/kg, i.p.) plus xylazine (8 mg/kg; i.m.) and then intracardially perfused with PBS 
followed by PBS-4% paraformaldehyde solution. Tissue processing was done as 
previously described [8]. 
 
2.6. Immunohistochemistry 
Immunohistochemistry of C5 sections for neuronal cell counting and astrocytic glial 
determination was performed as described elsewhere [23]. Anti-NeuN monoclonal 
antibody (1:200, Millipore, CA, USA) for identification of neurons, or anti-GFAP 
polyclonal anti-rabbit antibody (Dako Denmark, ready to use) to identify astrocytes 
were used. The EnVision detection system + HRP system labelled anti-mouse or anti-
rabbit (DakoCytomation) was applied during 45 min. Sections were then rinsed 
threefold in PBS-T. Liquid 3,3-diaminobenzidine tetra-hydrochloride (DAB) (Vector 
Laboratories Inc., CA, USA) was used as chromogen and Hill’s hematoxylin was used 














2.7. Image analysis  
Images of immunohistochemically stained C5 sections were captured using a digital 
camera (Olympus DP73, Japan) attached to a microscope (Olympus BX53, Japan). To 
create a complete map of the entire C5 segment taken with a 40x objective, images were 
captured using a digital image analyzer (cellSens Dimension, V1.7, Olympus 
Corporation, Japan) and stitched them using an automatic Multiple Image Alignment 
process. No further processing was necessary after obtaining the original images.  
 
2.7.1. Morphometry  
For determining variations in the area of both ipsilateral and contralateral sides in 
coronal-sectioned segments, possibly induced by the injected solutions, morphometric 
analysis was performed using an image analysis software (ImagePro Plus -v6.3, Media 
Cybernetics, MA, USA). For that purpose, each side of the spinal cord segment was 
delimited using a ROI (region of interest) and the actual area determined. In each group, 
the ipsilateral areas were statistically tested against their contralateral areas and against 
the same side areas in all the experimental groups. 
For astrocytes estimation as an indicator of inflammatory process, GFAP 
immunostained area was considered. For that purpose, color segmentation to detect 
positively stained cells inside a ROI (as previously defined) was applied and its area 
was calculated [16, 24]. In all cases, estimation of immunostaining was carried out in 
sections located up to 500 μm in front of and behind the injection site. 
  
2.7.2. Neuronal counting 
To determine the total number of neurons per section, color segmentation was 













Immunohistochemically stained images were used to estimate the number of cells 












where, N = total estimated number of cellular bodies; d = length (µm) of the rostro-
caudal axis of the cervical segment being assessed (2 mm); n = number of non-
contiguous (120 µm apart) slices counted per cervical segment (n = 5); s = thickness of 
the section (20 µm); x = number of perikarya counted per non-contiguous slice assessed. 
Therefore, N represents approximately the total number of neurons present in the 
cervical segment.  
 
8. Statistical analysis  
The variables: (A) heat sensitivity test and (B) suspension from a horizontal wire mesh 
pole were analyzed as repeated measures on the same animal at different times [26]. All 
models were fitted with SAS software for mixed models (Proc Mixed and Proc 
Glimmix, SAS v.9.3, USA). Differences between treatments effects at any given day pi 
were estimated as linear contrasts [27], whenever the test for treatments with degrees of 
freedom corrected by the procedure of Kenward and Roger [28], deemed the 
corresponding test to be significant (P < 0.05). Therefore, Figure 1A-B depict the 
estimated evolution of the treatment mean response across times for the corresponding 
response variable.  
The analysis of the ladder rung walking test was analyzed using procedures reviewed by 
Fletcher et al. [29], because one third of the data were measured as zeros. In the first 













and the zeros were kept as such. A generalized mixed model was fitted to the Binomial 
response variable with a logit link function. The only fixed effect in the model was 
treatment and the error covariance structure displayed heteroskedasticity due to day 
nested within treatment. The second stage considered only the non-zero values of the 
test. The zeros were taken as missing data [29]. The Gaussian model had treatments as 
fixed effects and the error covariance structure reflected heteroskedasticity due to 
treatment effects. The heterogeneity of variance motivated a change in the level of 
significance of the corrected F-test for this variable from 0.05 to 0.10, because 
differences found between treatments were biologically meaningful. Gaussian models 
were adjusted with Proc Mixed and the Binomial ladder rung walking test with Proc 
Glimmix. 
The remaining data were analyzed by one-way analysis of variance (ANOVA) and 
Holm Sidak’s test for multiple comparisons was used as a post-hoc test. Significance 
was assumed at values of P < 0.05. All these tests were analyzed using the statistical 




3.1. Behavioral tests 
3.1.1. Heat sensitivity test 
Significant differences between groups for all days pi were found (Fig. 1A). KA1 group 
showed significant differences against sham, L05 and KA1L05 groups at all days pi. 
Sham group also showed significant differences against L05 group at day 7 pi, and 














3.1.2. Suspension from a horizontal wire mesh pole 
Rats in KA1L05 group had a significantly longer suspension time than those of the KA1 
and L05 groups at days 1, 2, 3 and 7 pi (Fig. 1B). Sham group was significantly 
different from KA1L05 group at days 1 and 3 pi. In turn, the KA1 group showed a 
significantly shorter suspension time in comparison with L05 animals at days 1 and 2 pi, 
and in comparison with sham group at day 2 pi.  
 
3.1.3. Ladder rung walking test  
For the ipsilateral side, heterogeneity of variances related to the treatments was verified 
in the Gaussian analysis, being significant the effect of the KA1 treatment in 
comparison with the other treatments (P < 0.10). (Fig. 1C-D). For the contralateral side, 




Spinal cord sections of all groups showed some polymorphonuclear cells infiltration and 
minor hemorrhagic areas at the injection site. This pattern corresponds to the 
penetration point and the path of the injection needle as was described elsewhere [8]. 
Slides of sham group showed a few swollen neurons in sections relatively closed to the 
entry point of the needle (from Lamina IV up to Lamina VI). Neurons of L05 group 
showed a similar aspect to that observed in the sham group at the ipsilateral side. 
Neurons were almost absent at the ipsilateral side of the KA1 group, mostly at the 
ventral horn, whereas KA1L05 group displayed a similar pattern to that presented by 

















Comparison of the coronal-sectioned areas of both sides of the C5 sections showed a 
significant increase of the ipsilateral side area of KA1 animals in comparison to L05 
group at day 1 pi (P = 0.0077) (Fig. 2B-C). No significant differences were observed 
for the contralateral section area among groups along the experiment.  
GFAP immunostained area showed a significant increase in sham animals in 
comparison to L05 group at day 1 pi (P = 0.0083) at the ipsilateral side (Fig.  2D). At 
day 3 pi, sham animals showed a significant increase in the immunostained area in 
comparison to L05 and KA1L05 groups (P = 0.0235). The immunohistochemical 
identification of astrocytes showed that KA1 animals increased their immunostained 
area in comparison to L05 and KA1L05 rats at days 1 pi (P = 0.0435) and 3 pi (P = 
0.0235). At the contralateral side the immunostained area of the sham group was 
significantly higher than those of L05 and KA1L05 groups at days 1 and 3 pi (P = 
0.0066 and P = 0.0345, respectively) and the immunostained area of KA1 group was 
significantly higher than those of L05 and KA1L05 groups at day 3 pi (P = 0.0345) 
(Fig. 2E). Figure 2F1-2 shows the immunostained area of the ipsilateral ventral horn of 
KA1 and KA1L05 groups at day 2 pi. 
 
3.4. Neuronal counting 
Neuronal counting based on NeuN positive stained neurons was performed for both 
ipsilateral and contralateral sides. No significant differences were found in the number 













significant decrease in the number of neurons at the ipsilateral side in comparison to the 
other groups at days 1 pi (P = 0.0005), 2 pi (P = 0.0079), 3 pi (P = 0.0090) and 7 pi (P = 
0.0023) (Fig. 3A-B). No differences were found at the contralateral side at any day pi 
among groups. Figure 3C shows the NeuN immunohistochemical staining of neurons 
of KA1 and KA1L05 groups at day 2 pi. 
Estimation of the total number of neurons for the entire segment was performed. Values 
per each group and day pi are shown in Table 2. Significant results were observed for 
the KA1 group in comparison to the remaining groups at days 1 pi (P = 0.0024) and 3 pi 
(P = 0.0076) and against KA1L05 group at day 7 pi (P < 0.0001). 
 
4. Discussion 
In the present work we evaluated whether lidocaine could prevent the harmful effects of 
the excitotoxicity induced by KA at the spinal cord when they are simultaneously 
injected. As previously stated [8], KA-induced sensitive and motor impairments were 
significant for the first two days after injection of the drug, and progressively reverted 
towards day 7 pi. Nevertheless, using the simultaneous injection of 0.5% lidocaine and 
KA, none of those impairments were observed during the entire experiment, suggesting 
a potential neuroprotective effect of lidocaine.  
In our observations, KA mainly affected the middle region and the ventral horn of the 
C5 spinal cord segment. In the rat spinal cord, the distribution of kainate receptor 
subunits is primarily found in the utmost Laminae of the dorsal horn and at the level of 
motoneurons [5, 18]. Since AMPA and NMDA receptor subunits are also abundantly 
expressed in the dorsal and ventral horns it was suggested that even at lower 
concentrations than that used in our experiments the effects of KA may contribute to the 













glutamatergic neurons [5]. However, using the simultaneous injection of lidocaine and 
KA the previously changes described were not found.  
We found that KA-injected rats also showed lower heat sensitivity up to day 7 pi, but 
this effect disappeared by day 14 pi. These results suggest a possibly reversible 
excitotoxic effect of KA, as reported by Sun et al. [30]. On the other hand, animals 
receiving simultaneous injection of 0.5 % lidocaine and KA were more reactive to heat, 
more resistant in the horizontal wire mesh pole and showed minimal errors in the ladder 
rung walking test, as compared to KA1 group at almost all pi days. This would also 
indicate that muscle strength was not compromised, as in some motor neuropathies [1]. 
In addition, these animals showed no other tissue damage than that inflicted by the 
introduction of the needle, as it was also observed in sham animals. Similarly, when the 
same anesthetic was intravenously administered 30 min before, during and after a 
cerebral ischemia, the extent, severity and intensity of the hippocampal lesions were 
reduced [12]. On the other hand, in our model, KA induced an inflammatory reaction in 
which an increase in astrocytes was observed, with peaks of reactivity at days 1 and 3 pi 
[31] on the ipsilateral side, and a reduction on day 2 pi, as was previously described 
[24]. It is known that astrocytes can detect the presence of injury or stress factors in 
their microenvironment and therefore be activated [32]. This astrocytic reaction was not 
observed in animals that simultaneously received KA and lidocaine.  
As for the contralateral side response, it may be due to both the release of different 
cerebral or blood factors as a result of the injury and the migration of activated 
astrocytes as was discusses elsewhere [16]. This reaction may correspond to a 













In addition, L05 group showed lower astrocytic reaction as compared to sham group, as 
it has been recently reported [16]. These results support the well-known anti-
inflammatory effect of lidocaine.  
Neuronal counting was statistically higher when lidocaine was simultaneously injected 
with KA in comparison with those animals receiving only KA, both in individual 
sections as well as in the whole C5 segment. There is evidence about the reversibility of 
the effects caused by KA [8, 30] which is noticeable in the functional recovery of the 
injected animals by day 14 pi. Besides, there is evidence of tissue regeneration and cell 
repopulation processes in animals injected by the same route and with the same 
chemical agent [23]. 
It is known that exposure of neuronal populations to KA triggers a sustained Ca2+ intake 
and an overproduction of reactive oxygen species, thus leading to death of cells by 
excitotoxicity, which emulates the excessive release of glutamate [33]. Lin et al. [34] 
showed that lidocaine affects Ca2+-dependent exocytosis in vitro and consequently 
inhibits the release of glutamate from the presynaptic nerve terminals. In addition, Chiu 
et al. [33] showed the neuroprotective effect of lidocaine in vivo.  
It is known that lidocaine blocks Na+ channels [35] and this effect reduces neuronal 
depolarization with different beneficial effect, such as the reduction of Ca2+ influx and 
water and chloride uptake [36]. Other studies support the use of Na+ channel blockers to 
provide neuroprotection and functional recovery in neurodegenerative diseases, 
supporting other beneficial effects of the Na+ blockers on other channels or intracellular 















According to our results, 0.5% lidocaine prevents the excitotoxicity induced by KA 
when both drugs are simultaneously injected. This would allow us to conclude that 
lidocaine could be considered as a neuroprotective drug in diseases and models that 
include excitotoxicity as the primary mechanism of injury and used as a promising 
treatment for localized spinal cord injuries. 
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Day pi Sham L05 KA1 KA1L05 Total n 
0 15 25 25 25 90 
1 15 25 25 25 90 
2 12 20 20 20 72 
3 9 15 15 15 54 
7 6 10 10 10 36 
14 3 5 5 5 18 
Table 1. Number of animals (n) participating in each behavioural test.  
Numbers express the total number of animals of each group that participated in the 
















Day pi Sham L05 KA1 KA1L05 
0     
1 214300 ± 14278 248100 ± 19919 114300 ± 15500* 288400 ± 12154 
2 269000 ± 27628 267700 ± 9200 127700 ± 12400 255525 ± 17456 
3 261350 ± 8950 233950 ± 12150 115800 ± 5000* 266600 ± 20061 
7 221733 ± 50432 227800 ± 3500 103900 ± 11400* 279167 ± 23354 
14 263900 ± 21099 238550 ± 23050 107750 ± 7550 228167 ± 5664 
Table 2. Estimation of the total number of neurons for the entire C5 segment. Data are 
expressed as Mean ± SEM. The total number of neurons for the C5 segment was 
significantly lower for the KA1 group in comparison with the other groups for days 1 














Legends to the figures 
Fig. 1 Behavioural tests. Estimated mean responses for: A. Heat sensitivity test. B. 
Suspension from a horizontal wire mesh pole. C. Ladder rung walking test performance 
on ipsilateral side. Step errors (scores 0-2) average as percent of the total number of 
steps made in each trial. D. Contralateral side of the same test. In all cases, data are 
expressed as estimated mean ± SEM. * Days where significant results were observed. 
P-values and significance levels from the repeated measures test are observed at each 














Fig. 2 Inflammatory reactivity of the C5 spinal cord segment. A. Histological aspect 
of a C5 section of KA1 (A1) and KA1L05 (A2) showing distribution and aspect of 
neurons at their ipsilateral sides at day 2 pi. At A1, ventral horn neurons are almost 
missing. The remaining neurons are retracted or with vacuolated cytoplasm (arrows). 
Bar = 100 µm. B. Ipsilateral section area measurement. # KA1 vs. L05 (P < 0.05). C. 
Contralateral section area measurement. D. Ipsilateral GFAP-immunostained area. * 
sham significance against other groups; # KA1 significance against other groups (P < 
0.05). E. Contralateral GFAP-immunostained area. * sham significance against other 
groups; # KA1 significance against other groups (P < 0.05). In all cases, data are 
expressed as mean ± SEM. F1 and F2 are an immunohistochemical staining against 
GFAP positive cells (arrows) at the ipsilateral side of KA1 and KA1L05, respectively, 




























Fig. 3 Neuronal counting. Data are expressed as mean ± SEM. A. Ipsilateral counting 
#KA1 vs. the remaining groups (P<0.05). B. Contralateral counting. C. 
Immunohistochemical staining for detection of NeuN positive cells at day 2 pi: C1, 
ipsilateral side of KA1 group. Few intact neurons can be seen (arrows); C2, ipsilateral 
side of KA1L05 group. Bar = 50 µm. 
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